Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Darby

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Plos One|June 4, 2011
Criterion and construct validity of the CogState Schizophrenia Battery in Japanese patients with schizophreniaTaisuke Yoshida, Motomu Suga, Kunimasa Arima, et al.
BMJ Open|December 17, 2021
Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trialLucy Vivash, Kelly L Bertram, Charles B Malpas, et al.
Neurobiology of Aging|June 18, 2013
BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's diseaseYen Ying Lim, Victor L Villemagne, Simon M Laws, et al.
Journal of the Neurological Sciences|November 22, 2024
Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disordersDhamidhu Eratne, Matthew J Y Kang, Courtney Lewis, et al.
International Psychogeriatrics|November 21, 2013
Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)Kathryn A Ellis, Cassandra Szoeke, Ashley I Bush, et al.
The Australian and New Zealand Journal of Psychiatry|July 21, 2023
Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disordersDhamidhu Eratne, Matthew Kang, Charles Malpas, et al.
Transplantation and Cellular Therapy|March 9, 2026
A computerised cognitive test for immune effector cell-associated neurotoxicity syndrome in chimeric antigen receptor T-cell therapy recipients: a pilot studyChristina Kazzi, David Darby, Miriam Wronski, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyQiao-Xin Li, Victor L Villemagne, James D Doecke, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 29, 2022
Clinical impact of whole-genome sequencing in patients with early-onset dementiaAamira J Huq, Bryony Thompson, Mark F Bennett, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Bridging Big Data: Procedures for Combining Non-equivalent Cognitive Measures from the ENIGMA ConsortiumEamonn Kennedy, Shashank Vadlamani, Hannah M Lindsey, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Plos One|June 4, 2011
Criterion and construct validity of the CogState Schizophrenia Battery in Japanese patients with schizophreniaTaisuke Yoshida, Motomu Suga, Kunimasa Arima, et al.
BMJ Open|December 17, 2021
Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trialLucy Vivash, Kelly L Bertram, Charles B Malpas, et al.
Neurobiology of Aging|June 18, 2013
BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's diseaseYen Ying Lim, Victor L Villemagne, Simon M Laws, et al.
Journal of the Neurological Sciences|November 22, 2024
Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disordersDhamidhu Eratne, Matthew J Y Kang, Courtney Lewis, et al.
International Psychogeriatrics|November 21, 2013
Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)Kathryn A Ellis, Cassandra Szoeke, Ashley I Bush, et al.
The Australian and New Zealand Journal of Psychiatry|July 21, 2023
Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disordersDhamidhu Eratne, Matthew Kang, Charles Malpas, et al.
Transplantation and Cellular Therapy|March 9, 2026
A computerised cognitive test for immune effector cell-associated neurotoxicity syndrome in chimeric antigen receptor T-cell therapy recipients: a pilot studyChristina Kazzi, David Darby, Miriam Wronski, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyQiao-Xin Li, Victor L Villemagne, James D Doecke, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 29, 2022
Clinical impact of whole-genome sequencing in patients with early-onset dementiaAamira J Huq, Bryony Thompson, Mark F Bennett, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Bridging Big Data: Procedures for Combining Non-equivalent Cognitive Measures from the ENIGMA ConsortiumEamonn Kennedy, Shashank Vadlamani, Hannah M Lindsey, et al.
Pageof 9